MDIs and the Need for Greener Propellants
By Stephanie Vine, Julian Upton
October 27, 2025
Regulations are pushing companies to more environmentally friendly propellants, but how should capacity be scaled up?
5 min read
False
By Stephanie Vine, Julian Upton
October 27, 2025
Regulations are pushing companies to more environmentally friendly propellants, but how should capacity be scaled up?
5 min read
By Stephanie Vine
October 20, 2025
From compounding to new opportunities, we look at some of the insights shared at an AAPS workshop
11 min read
October 16, 2025
Researchers at the University of Bath are bringing the vision of pills as an alternative to injections for life-saving biologics closer to reality.
6 min read
October 15, 2025
With remarkable successes come inevitable hurdles. Find out what experts had to say about GLP-1 drug development during an AAPS workshop.
8 min read
By Stephanie Vine
September 22, 2025
Patients want smarter, simpler drug delivery options – and it’s accelerating the self-injection market.
4 min read
By Tran Pham
September 16, 2025
As antibody drug conjugates continue to evolve, so too must analytical approaches for characterization. Here’s a snapshot of just some of the interesting research taking place.
3 min read
September 15, 2025
Patients say they are ready for self-injectables, but are healthcare providers? And what further innovation in devices is needed?
9 min read
September 5, 2025
Meet the drug-delivery nanoparticles that self-assemble with temperature changes.
3 min read
By Hilary Brooks
August 20, 2025
Pharma is investing big in oligonucleotides, but what is it that makes this class of drugs so special? We find out.
10 min read
By Stephanie Vine
July 28, 2025
Established medicine to swap to new formulation.
2 min read
False
False
False